MSc Strategy Organisation & Management

Jesper Elsgaard has extensive experience in strategic optimization, brand launching, Life Cycle Management strategies, and forecasting. Currently, he is Senior Director of Global Governmental Affairs at Bavarian Nordic A/S. Prior, Jesper has lead the North Europe Consulting team (Benelux, UK, France and Nordics) in IMS Consulting Group with success, and turned around the whole organization in terms of operational efficiency and client centricity. He has also worked as Global Marketing Director at Novo Nordisk where he was responsible for launching Levemir in 43 countries, and as a Management Consultant to McKinsey & Company where he participated in strategic and operational projects for top-10 companies in Denmark. Regarding his academic background, Jesper possesses a Master of Science degree in Strategy, Organization and Management from Copenhagen Business School, and has completed leadership programs at Harvard Business School, IMD International Business School and Ashridge Management School.

Maarten has 25 years of International experience managing commercial processes in leading Global Healthcare Companies. Maarten has substantial knowledge in successfully bringing new products, services and technologies to commercialization in different markets. His experience ranges from working with Pharmaceutical Products at different life-cycle stages in Global Companies like Merck&Co to leading medical divice organizations like; Dako, Agilent Technologies and Abbott Laboratories. International experience in Healthcare Business Consulting, helping Technology Start Ups with Product Launch Excellence, Stakeholder Management, Strategy Development and Commercial Leadership. Maarten holds an Executive MBA from Henley Business School, The UK.

Prior to Aquilo, Vasco Aguiar worked in product management at Vestas Wind Systems in Denmark. He has studied and worked abroad for 7 years, in countries including Chile, Switzerland, Portugal and Denmark, providing him with an international perspective. At Aquilo, one of Vasco’s strengths is financial modeling and analysis. He holds an M.Sc. in Economics and Business Administration, with a specialization in International Business from Aarhus University.

Franz is an expert with numbers and master complicated financial calculations and scenarios. Prior to joining aquilo, Franz proved his financial analysis skills within the Counterparty Risk Management Department of UniCredit AG. As part of Deloitte´s Transaction Advisory Team, he worked with a range of due diligence processes. Franz holds a B.Sc. in International Business from Augsburg University, Germany and Universidad del Desarrollo, Santiago de Chile. Currentl and a M.Sc. degree in Finance and Investments at Copenhagen Business School.

Tenna Andersen has a background in research; studying changes in the early stages of diabetes. This experience has given her a broad analytical skillset and a comprehensive disease understanding. She has further proven her analytical skills working in a biotech start-up focused on next-generation sequencing. Tenna holds an M.Sc. in Molecular Biomedicine, specialized in Neuropsychology from the University of Copenhagen.

Before joining Aquilo, Peter Nielsen co-founded a mental health project where his tasks ranged from strategy development to partner relations and administration. He has a strong sense for innovation, having worked as a product owner and project lead in R&D and commercial at LEO Pharma. Peter holds an M.Sc. in Business Administration and Information Systems from Copenhagen Business School.

M.Sc. Finance 

Søren B. Andersson works at Jeudan, the largest listed Danish real estate company, where he currently holds a position as Finance Director and within a foreseeable future to become CFO as part of a planned generational handover. Prior to Jeudan, Søren worked 12 years at Demant, a listed global hearing healthcare leader, most recently as Vice President of Investor Relations and Corporate Strategy. In this role Søren worked closely with the Executive Board thus gaining deep insight into the dynamics in managing a global healthcare business. Prior to Demant, Søren worked five years in consulting including several positions at Accenture. Søren has obtained considerable indepth global experience in a wide variety of areas such as life science, capital markets, M&A, business development and strategy. Søren holds a M.Sc. in Finance & Accounting from Copenhagen Business School and ESADE in Barcelona and is member of the Board in BLS Invest.”

Lucinda Nuzum has a background in molecular biology from several international research institutions. Prior to Aquilo, she worked with the Copenhagen Institute for Future Studies. Lucinda has lived and worked in 4 different countries: Finland, the U.S.A., Spain and Denmark. She holds an M.Sc. in Biotechnology from the University of Copenhagen.

Before joining Aquilo, Giorgia Guarnieri contributed to market penetration and business model innovation activities for a well-known luxury brand in Italy. She holds a B.Sc. in Economics and Management from the University of Trento.

Thomas has extensive experience from product development within public & private healthcare organisations and life sciences (biologicals) & medtech companies. Thomas raised the first seed and follow-on capital for Genmab A/S, Zealand Pharma A/S, CMC Biologicals A/S, TopoTarget A/S and Zymenex A/S until their IPO or asset sale - collectively going from a market cap of zero in 1998 to currently more than EUR10b, +500 employees and +5 medicines approved for the treatment of several unmet medical needs. MD, MBA from Denmark and certified Regulatory Affairs consultant from Johns Hopkins University & RAPS, USA. 

Prior to joining Aquilo, Hans Christian Jørgensen divided his time between London and Tokyo where for 5 years he ran a medical device start-up founded by himself and his Japanese business partner. During this time, he was involved in most aspects of the business ranging from project management and strategy, to marketing and sales. This experience has given him a broad skillset and a comprehensive understanding of the MedTech industry and the challenges the industry faces today. Having spent nearly 10 years abroad, Hans Christian has acquired an international outlook and a deep understanding of other cultures. He holds an M.Sc. in Strategic Market Creation from Copenhagen Business School.